Product Program year 2025 Source: CMS Open Payments

cobas 6000 Core Unit

Device Centralized Diagnostics

PDI 04015630938551

Open in the dashboard

General payments

$78,016

35 payments

Research payments

$4,944,017

44 payments

Through program year 2025, $78,016 in general payments and $4,944,017 in research payments were reported against cobas 6000 Core Unit (Centralized Diagnostics).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

8 rows
Year Kind Amount Payments
2025 Research $1,047,137 2
2024 General $9,860 5
2024 Research $1,078,318 4
2023 Research $613,215 11
2022 General $353 5
2022 Research $956,357 10
2021 General $67,803 25
2021 Research $1,248,990 17

Breakdown

Who paid General payments · program years 2021–2024
  1. Roche Diagnostics Corporation $67,266 34 payments
  2. Roche Diagnostics Operations, Inc. $10,750 1 payment
Top recipients General payments · program year 2024
  1. David Gaston Medical Microbiology · Nashville, TN $3,345 34% · 1 payment
  2. Peter McCaffrey Anatomic Pathology · Galveston, TX $2,455 25% · 1 payment
  3. Sarosh Rana Maternal & Fetal Medicine · Chicago, IL $2,405 24% · 1 payment
  4. Casey Pinto Nurse Practitioner, Family · Harrisburg, PA $1,493 15% · 1 payment
  5. Eric Vail Anatomic Pathology & Clinical Pathology · West Hollywood, CA $162 2% · 1 payment

Each share is of general payments naming this product in 2024.

Specialties paid General payments · program year 2024
  1. Medical Microbiology Pathology $3,345 34% · 1 practitioner
  2. Anatomic Pathology Pathology $2,455 25% · 1 practitioner
  3. Maternal & Fetal Medicine Obstetrics & Gynecology $2,405 24% · 1 practitioner
  4. Nurse Practitioner, Family Nurse Practitioner $1,493 15% · 1 practitioner
  5. Anatomic Pathology & Clinical Pathology Pathology $162 2% · 1 practitioner

Each share is of general payments naming this product to practitioners with a specialty in 2024. Each practitioner is counted under their primary specialty.

Where the money went General payments · program year 2024
  1. Tennessee $3,345 34% · 1 recipient
  2. Texas $2,455 25% · 1 recipient
  3. Illinois $2,405 24% · 1 recipient
  4. Pennsylvania $1,493 15% · 1 recipient
  5. California $162 2% · 1 recipient

Each share is of general payments naming this product in 2024 where a state was reported.

35 general · 44 research

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record